| Bioactivity | Elobixibat is a potent ileal bile acid transporter (IBAT) inhibitor with IC50 values of 0.53 ± 0.17 nM, 0.13 ± 0.03 nM, and 5.8 ± 1.6 nM for human IBAT, mouse IBAT, and canine IBAT. | ||||||||||||
| Target | IC50: 0.53±0.17 nM (human IBAT), 0.13±0.03 nM (mouse IBAT), 5.8±1.6 nM (canine IBAT). | ||||||||||||
| Name | Elobixibat | ||||||||||||
| CAS | 439087-18-0 | ||||||||||||
| Formula | C36H45N3O7S2 | ||||||||||||
| Molar Mass | 695.89 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Wong BS, et al. Elobixibat for the treatment of constipation. Expert Opin Investig Drugs. 2013 Feb; 22(2):277-84. |
Elobixibat
CAS: 439087-18-0 F: C36H45N3O7S2 W: 695.89
Elobixibat is a potent ileal bile acid transporter (IBAT) inhibitor with IC50 values of 0.53 ± 0.17 nM, 0.13 ± 0.03 nM
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.